|
Qiu et al. 2007 [11]
|
China
|
13.5/15.1
|
17.5 ± 0.2/20.9 ± 0.4
|
47/80
|
8.6 ± 0.8/14.9 ± 0.9
| | | |
ELISA
|
|
Liu et al. 2012 [12]
|
China
|
13.7 ± 1.5/13.8 ± 1.4
|
17.8 ± 2.3/19.5 ± 2.2
|
95/46
|
7.0 ± 5.0/8.4 ± 5.8
|
23.7 ± 6.7/20.5 ± 5.6
|
0.33 ± 0.25/0.48 ± 0.41
| |
ELISA
|
|
Clark 2014 [23]
|
UK
|
None
|
17.2 ± 2.9/17.6 ± 2.8
|
180/3152
|
5.24 ± 4.26/6.28 ± 5.11
| | | |
ELISA
|
|
Tam et al. 2014 [18]
|
China
|
13.05 ± 0.52/12.93 ± 0.43
|
17.91 ± 2.20/18.64 ± 2.15
|
94/87
|
6.75 ± 5.01/7.26 ± 4.99
|
25.86 ± 6.49/23.43 ± 5.27
| | |
ELISA
|
|
Tam et al. 2016 [19]
|
China
|
12.91 ± 0.63/12.96 ± 0.45
|
17.59 ± 2.10/18.35 ± 2.23
|
148/116
|
8.1 ± 7.48/10.47 ± 8.34
|
26.46 ± 6.66/23.98 ± 6.95
|
0.28/0.39
| |
ELISA
|
|
Wang et al. 2016 [17]
|
China
|
12.81 ± 1.82/13.67 ± 1.67
|
17.66 ± 1.15/19.66 ± 0.91
|
31/15
|
7.62 ± 2.80/8.89 ± 4.15
| | | |
ELISA
|
|
Yu et al. 2018 [20]
|
China
|
12.43 ± 1.90/12.80 ± 1.22
|
17.83 ± 1.18/17.55 ± 1.35
|
105/40
|
6.55 ± 2.88/8.01 ± 3.12
| | |
6550 ± 2460/4460 ± 2020
|
ELISA
|
|
Gauzy et al. 2015 [22]
|
France
|
14.3 ± 1.4/13.9 ± 1.6
|
19.1 ± 2.6/18.5 ± 2.5
|
49/15
| | | |
261.9 ± 120.3/146.1 ± 59.2
|
Radioimmunoassay
|
|
Xiao et al. 2020 [21]
|
China
|
14.52 ± 2.24/14.23 ± 2.04
|
17.76 ± 2.60/20.87 ± 4.54
|
83/44
| | | |
27.33 ± 6.57/15.81 ± 3.82
|
ELISA
|
